Skip to main content
Home Home
  • Learn
    • Why TraceLink
    • Products
    • Knowledge Base
  • Share
    • Community
Home Home

Network

    • Log in
      • TraceLink Classic

        app.tracelink.com

Breadcrumb

  1. Knowledge Base
  2. Case Study: TraceLink | FDA...

Case Study: TraceLink | FDA Pilot - Product Traceability Under 2023 DSCSA Regulations - A Business Process-Led Design for a Blockchain Network

  • PDF
  • Share
    • LinkedIn
    • Twitter
    • Facebook
    • Mail
October 28, 2019

TraceLink's breakthrough blockchain solution, Trace Histories, can help pharma clients comply with US Drug Supply Chain Security Act regulations which go into effect in 2023. With Trace Histories, customers can respond to product trade requests while simultaneously safeguarding confidential commercial information. Read our new poster, which was featured at FutureLink Nashville, for additional details. 

TraceLink Poster

 
View Poster Session Gallery

 

 
Case Study DSCSA 2023 Regulatory/Compliance

Select Language

Select your preferred language

  • Legal & Trust
  • TraceLink University
  • Support
  • Contact Us
  • Careers
  • Sitemap

© TraceLink Inc. 2009-2022 All Rights Reserved

  • Log in
    • TraceLink Classic

      app.tracelink.com

  • Legal & Trust
  • TraceLink University
  • Support
  • Contact Us
  • Careers
  • Sitemap